Burden of community-acquired pneumonia in adults over 18 y of age

References

• Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1(8534):671-4; PMID:2882091; https://doi.org/10.1016/S0140-6736(87)90430-2
   PubMed Web of Science ®Google Scholar
• Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, Kurki S, Rönnberg RR, Seppä A, Soimakallio S, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137(9):977-88; PMID:8317455; https://doi.org/10.1093/oxfordjournals.aje.a116770
   PubMed Web of Science ®Google Scholar
• Foy HM, Cooney MK, Allan I, Kenny GE. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA 1979; 241(3):253-8; PMID:758528
   PubMed Web of Science ®Google Scholar
• Mertz D, Johnstone J. Modern management of community-acquired pneumonia: Is it cost-effective and are outcomes acceptable? Curr Infect Dis Rep 2011; 13(3):269-77; PMID:21400249; https://doi.org/10.1007/s11908-011-0178-8
   PubMedGoogle Scholar
• Brar NK, Niederman MS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis 2011; 5(1):61-78; PMID:20935033; https://doi.org/10.1177/1753465810381518
   PubMedGoogle Scholar
• Gadsby NJ, Russell CD, McHugh MP, Mark H, Conway Morris A, Laurenson IF, Hill AT, Templeton KE. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 2016; 62(7):817-23; PMID:26747825; https://doi.org/10.1093/cid/civ1214
   PubMed Web of Science ®Google Scholar
• Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM. Community-acquired pneumonia requiring hospitalization among U.S. Adults N Engl J Med 2015; 373(5):415-27; https://doi.org/10.1056/NEJMoa1500245
   PubMed Web of Science ®Google Scholar
• Sağlık Bakanlığı. Temel Sağlık Hizmetleri Genel Müdürlüğü. Genişletilmiş Bağışıklama Programı Genelgesi. Sayı: B100TSH0110005, Tarih: 13.03.2009/7941.
   Google Scholar
• Niederman MS. Recent advances in community-acquired pneumonia: inpatient and outpatient. Chest 2007; 131(4):1205-15; PMID:17426229; https://doi.org/10.1378/chest.06-1994
   PubMed Web of Science ®Google Scholar
• Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 2008; 8(12):785-95; PMID:19022193; https://doi.org/10.1016/S1473-3099(08)70281-0
   PubMed Web of Science ®Google Scholar
• T.C. Sağlık Bakanlığı. Refik Saydam Hıfzıssıhha Merkezi Başkanlığı, Hıfzıssıhha Mektebi Müdürlüğü, Başkent Üniversitesi Ulusal Hastalık Yükü ve Maliyet-Etkililik Projesi; 2004
   Google Scholar
• Brown PD. Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care? Pharmacoeconomics 2004; 22(7):413-20; PMID:15137880; https://doi.org/10.2165/00019053-200422070-00001
   PubMed Web of Science ®Google Scholar
• Polverino E, Torres Marti A. Community-acquired pneumonia. Minerva Anestesiol 2011; 77(2):196-211; PMID:21242952
   PubMed Web of Science ®Google Scholar
• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67(1):71-9; PMID:20729232; https://doi.org/10.1136/thx.2009.129502
   PubMed Web of Science ®Google Scholar
• United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Ageing 2013. ST/ESA/SER.A/348. Available from: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf
   Google Scholar
• Sato R, Gomez Rey G, Nelson S, Pinsky B. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥ 50 years. Appl Health Econ Health Policy 2013; 11(3):251-8; PMID:23605251; https://doi.org/10.1007/s40258-013-0026-0
   PubMedGoogle Scholar
• Yu H, Rubin J, Dunning S, Li S, Sato R. Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc 2012; 60(11):2137-43; PMID:23110409
   PubMed Web of Science ®Google Scholar
• Reyes S, Martinez R, Vallés JM, Cases E, Menendez R. Determinants of hospital costs in community-acquired pneumonia. Eur Respir J 2008; 31(5):1061-7; PMID:18448502; https://doi.org/10.1183/09031936.00083107
   PubMed Web of Science ®Google Scholar
• Tichopad A, Roberts C, Gembula I, Hajek P, Skoczynska A, Hryniewicz W, Jahnz-Rozyk K, Prymula R, Solovič I, Kolek V. Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia. PLoS One 2013; 8(8):e71375; PMID:23940743; https://doi.org/10.1371/journal.pone.0071375
   PubMed Web of Science ®Google Scholar
• Song JH, Thamlikitkul V, Hsueh PR. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. Int J Antimicrob Agents 2011; 38(2):108-17; PMID:21683553
   PubMed Web of Science ®Google Scholar
• Doruk S, Tertemiz KC, Kömüs N, Uçan ES, Kilinç O, Sevinç C. Community acquired pneumonia and direct hospital cost. Tuberk Toraks 2009; 57(1):48-55; PMID:19533437
   PubMedGoogle Scholar
• Aujesky D, Fine MJ. Community-acquired pneumonia: treatment at home or in the hospital? Am J Med 2008; 121(12):1038-40; PMID:19028194
   PubMed Web of Science ®Google Scholar
• Kozma CM, Dickson M, Raut MK, Mody S, Fisher AC, Schein JR, Mackowiak JI. Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP). J Med Econ 2010; 13(4):719-27; PMID:21091099; https://doi.org/10.3111/13696998.2010.536350
   PubMedGoogle Scholar
• Raut M, Schein J, Mody S, Grant R, Benson C, Olson W. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US. Curr Med Res Opin 2009; 25(9):2151-7; PMID:19601711; https://doi.org/10.1185/03007990903102743
   PubMed Web of Science ®Google Scholar
• Tokgöz Akyıl F, Hazar A, Erdem İ, Pehlivan Öneş C, Yalçınsoy M, Irmak İ, Kasapoğlu US. Hospital treatment costs and factors affecting these costs in community-acquired pneumonia. Turk Thorac J 2015; 16:107-13; https://doi.org/10.5152/ttd.2015.4609
   Web of Science ®Google Scholar
• Bartolomé M, Almirall J, Morera J, Pera G, Ortún V, Bassa J, Bolíbar I, Balanzó X, Verdaguer A; maresme community-acquired pneumonia study group (GEMPAC). A population-based study of the costs of care for community-acquired pneumonia. Eur Respir J 2004; 23(4):610-6; PMID:15083763; https://doi.org/10.1183/09031936.04.00076704
   PubMed Web of Science ®Google Scholar
• Lee JY, Yoo CG, Kim HJ, Jung KS, Yoo KH. Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases. Korean J Intern Med 2014; 29(6):764-73; PMID:25378975; https://doi.org/10.3904/kjim.2014.29.6.764
   PubMed Web of Science ®Google Scholar
• Polsky D, Bonafede M, Suaya JA. Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults. BMC Health Serv Res 2012; 12:379; PMID:23113880; https://doi.org/10.1186/1472-6963-12-379
   PubMed Web of Science ®Google Scholar
• Barlow G, Nathwani D, Davey P. The effect of implementing the British Thoracic Society community-acquired pneumonia guidelines on antibiotic prescribing and costs in a UK teaching hospital. Clin Microbiol Infect 2006; 12(5):498-500; PMID:16643534; https://doi.org/10.1111/j.1469-0691.2006.01387.x
   PubMed Web of Science ®Google Scholar
• Asche C, McAdam-Marx C, Seal B, Crookston B, Mullins CD. Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance. J Antimicrob Chemother 2008; 61(5):1162-8; PMID:18310136; https://doi.org/10.1093/jac/dkn073
   PubMed Web of Science ®Google Scholar
• Broulette J, Yu H, Pyenson B, Iwasaki K, Sato R. The incidence rate and economic burden of community-acquired pneumonia in a working-age population. Am Health Drug Benefits 2013; 6(8):494-503; PMID:24991378
   PubMedGoogle Scholar
• T. C. Sağlık Bakanlığı. Türkiye Halk Sağlığı Kurumu Risk Grubu Aşılamaları. Tarih: 17.06.2016, Sayı: 21001706.
   Google Scholar